Codes and Frequencies
Description
For women who have heard of cervical cancer, CERVCANEXAM indicates whether the woman has ever had a test or exam to see if she has cervical cancer.
Comparability — Index
Comparability
Along with universe differences, CERVCANEXAM has some differences in question wording. For example, the Phase 8 question wording refers to an unspecified cervical cancer test, while some country-specific question wording asks about a pap smear. See comparability text for details.
Comparability - Standard DHS
CERVCANEXAM is a country-specific variable in most phases of the DHS. In Phase 8, the standard variable CHD27 is included in the optional module on chronic disease, while the standard variable V484B covers whether the woman was ever tested for cervical cancer by a doctor or a health worker.
Comparability — Jordan [top]
The 2007, 2012, and 2017 Jordan surveys ask specifically whether the respondent has had a pap smear. Users may wish to compare CERVCANEXAM for the 2007 and 2012 Jordan surveys with CERVCANPAP, which indicates whether, in response to an open-ended question, the respondent reported receiving a pap smear.
Comparability — Lesotho [top]
The 2009 and 2014 Lesotho surveys ask specifically whether the respondent has had a pap smear. Users may wish to compare CERVCANEXAM for the 2009 and 2014 Lesotho surveys with CERVCANPAP, which indicates whether, in response to an open-ended question, the respondent reported receiving a pap smear.
Comparability — Namibia [top]
The 2000 Namibia survey asks specifically whether the respondent has had a pap smear. Users may wish to compare CERVCANEXAM for the 2000 Namibia survey with CERVCANPAP, which indicates whether, in response to an open-ended question, the respondent reported receiving a pap smear.
Comparability — South Africa [top]
The 2016 South Africa survey asks specifically whether the respondent has had a pap smear. Users may wish to compare CERVCANEXAM for the 2016 South Africa survey with CERVCANPAP, which indicates whether, in response to an open-ended question, the respondent reported receiving a pap smear.
Universe
- Benin 2017: Women age 15-49 in households selected for the men's survey.
- Burkina Faso 2021: All women age 15-49.
- Cambodia 2021: All women age 15-49.
- Cameroon 2018: All women age 15-49.
- Cote d'Ivoire 2011: Women age 15-49 who have heard of cervical cancer.
- Cote d'Ivoire 2021: All women age 15-49.
- Ghana 2022: All women age 15-49.
- India 2015: All women age 15-49.
- India 2019: Women age 15-49 who were present for and completed biomarker unit testing.
- Jordan 2007: Ever-married women age 15-49 who have heard of a pap smear.
- Jordan 2012: Ever-married women age 15-49 who have heard of a pap smear.
- Jordan 2017: Ever-married women age 15-49 who have heard of a pap smear.
- Jordan 2023: Ever-married women age 15-49.
- Kenya 2014: Women age 15-49, in households selected for the long questionnaire, who have heard of cervical cancer.
- Kenya 2022: Women age 15-49 in households selected for the men's survey.
- Lesotho 2009: Women age 15-49 who have heard of a pap smear.
- Lesotho 2014: Women age 15-49 who have heard of a pap smear.
- Lesotho 2023: Women age 15-49, in households selected for the men's survey.
- Madagascar 2021: Women age 15-49 in households selected for the men's survey.
- Mozambique 2022: All women age 15-49.
- Namibia 2000: All women age 15-49.
- Namibia 2013: Women age 15-49 who have heard of cervical cancer.
- Nepal 2022: All women age 15-49.
- Philippines 2022: All women age 15-49.
- Senegal 2023: All women age 15-49.
- South Africa 2016: Women age 15-49 in households selected for the adult health questionnaire.
- Tanzania 2022: All women age 15-49.
- Zimbabwe 2015: Women age 15-49 who have heard of cervical cancer.
